Bernard J. Wolfson Medical educators and health professionals warn that new federal student loan caps in…
Blog
A Listener's DIY Project Helps Others Deal With High Medical Bills – KFF Health News
Dan Weissmann In April, Thomas Sanford, a medical student who regularly listens to “An Arm and…
The FQHC model and medicine's moral promise
The Federally Qualified Health Center stands as perhaps the most eloquent institutional response to the perennial…
Philips and Nicolab collaborate to advance stroke care in India – Express Healthcare
Philips, a global leader in health technology, is expanding its collaboration with Nicolab, a pioneering company…
A Ticking Clock: How States Are Preparing for a Last-Minute Obamacare Deal – KFF Health News
Amanda Seitz and Julie Appleby, KFF Health News One family in Virginia Beach, Virginia, just found…
National Center of Technology Innovation for Dairy Debuts at the IDF World Dairy Summit, Showcasing Innovation to Drive Sustainability
SANTIAGO, Chile, Oct. 27, 2025 /PRNewswire/ — The highly anticipated 2025IDF World Dairy Summit took place…
Alphyn Expands Patent Estate with New U.S. Patent for Atopic Dermatitis Therapeutic
Patent covers active pharmaceutical ingredient with protection until 2041 ANNAPOLIS, Md., Oct. 27, 2025 /PRNewswire/ –Alphyn,…
TREMFYA® (guselkumab), the first and only IL-23 inhibitor with a fully subcutaneous treatment regimen, demonstrates durable remission in Crohn’s disease at two years
Clinical remission rates were over 85% for both TREMFYA® maintenance doses at 96 weeks in both…
MEDINET Japan and Stempeutics India signs option license agreement for Stempeucel product – Express Healthcare
MEDINET Japan and Stempeutics India (a group Company of Manipal Education & Medical Group) jointly announced…
Icotrokinra maintains standout combination of therapeutic benefit and a favorable safety profile in once-daily pill through 28 weeks in ulcerative colitis
Building on 12-week findings, icotrokinra demonstrated clinically meaningful outcomes at Week 28 with 31.7% of patients…